Last updated: August 26, 2025
Introduction
The World Intellectual Property Organization (WIPO) patent application WO2018102145 provides a comprehensive view into innovations within the pharmaceutical sector. This patent application, filed under the Patent Cooperation Treaty (PCT), addresses a specific composition or methodality intended for therapeutic use. Understanding its scope, claims, and the existing patent landscape is critical for stakeholders—whether R&D entities, generic manufacturers, or investors—interested in strategic patent positioning and freedom-to-operate analyses.
Scope of WO2018102145
WO2018102145 broadly pertains to a novel pharmaceutical formulation, therapeutic compound, or method for treating a specific medical condition. Its claims likely focus on bioactive agents, their compositions, manufacturing methods, or delivery systems. The scope can be segmented as follows:
-
Chemical Composition: The patent claims may cover a particular chemical entity or a class of compounds with specific structural features, potentially including derivatives, salts, or prodrugs.
-
Methodology of Use: It may encompass a novel therapeutic method—such as a dosing regimen or administration route—that enhances efficacy or reduces side effects.
-
Formulation and Delivery: The scope possibly extends to specific formulations, such as controlled-release matrices or targeted delivery systems, which may improve bioavailability or patient compliance.
-
Therapeutic Indication: Although not always explicit, the patent may specify particular disease indications—for example, oncology, inflammation, or infectious diseases—indicating the primary utility.
Claims Analysis
The specificity and breadth of patent claims define the enforceable scope:
Independent Claims
These typically define the core invention and often include:
- Chemical Compound(s): A structurally unique molecule with specific substituents, or a novel class. For example, a heterocyclic derivative with defined substituents claimed for use in a therapeutic context.
- Method of Treatment: Claims covering a method involving administering the compound to treat a certain disease, possibly with parameters such as dosage, frequency, or delivery vehicle.
Dependent Claims
- Narrower claims may specify particular chemical modifications, salts, polymorphs, or formulations.
- They could also define specific treatment regimes—such as combination therapies or patient populations (e.g., pediatric, elderly).
Claim Scope Evaluation
The claims' breadth is critical: overly broad claims risk invalidation if prior art exists, while overly narrow claims limit enforceability. Given typical strategy, WO2018102145 likely balances these by claiming:
- Core chemical entities or combinations.
- Specific formulations or delivery systems.
- Treatment methods with particular parameters.
Patent Landscape and Prior Art
Global Patent Context
The patent landscape surrounding WO2018102145 encompasses both foundational patents and subsequent filings:
- Pre-existing Patents: Prior art includes earlier patents covering similar compounds, formulations, or uses. For instance, if the compound shares structural motifs with known drugs, prior art could impact novelty.
- Competitive Patents: Other entities may have filed patents on analogous compounds or delivery technologies, potentially leading to patent thickets or freedom-to-operate concerns.
- Patent Family and Geographies: Typically, applicants seek patent protection across jurisdictions—US, EP, CN—that influence market access and litigation risks.
Patentability and Patent Landscape Analysis
- Novelty and Inventive Step: WO2018102145 appears to claim a novel aspect—likely a specific chemical structure or innovative formulation—distinguishing from prior art.
- Freedom to Operate (FTO): Given the abundance of patents in drug development, FTO analyses are essential before commercialization. Companies should scrutinize overlapping claims, especially those related to chemical classes or delivery methods.
- Legal Status and Expiry: Pending or granted status varies by jurisdiction; patent term calculations (generally 20 years from filing) must be tracked for potential infringement or licensing.
Strategic Implications
The patent landscape suggests competitive advantages if WO2018102145 claims an innovative compound or method not previously disclosed or claimed. However, overlapping patents could necessitate licensing negotiations or design-around strategies.
Summarized Insights
- Scope: Focused on a novel pharmaceutical compound or method, possibly within a therapeutic niche, with claims designed to protect both composition and use.
- Claims: Likely balanced between broad claims covering general classes or methods and narrower claims on specific embodiments, influencing enforceability.
- Patent Landscape: Characterized by existing patents on similar compounds, creating a competitive field requiring diligent FTO analysis.
- Legal and Commercial Strategy: The patent's strength depends on claim novelty, scope, and jurisdictional coverage—factoring into licensing, development, or litigation strategies.
Key Takeaways
- Comprehensive claim analysis is vital to ensure clarity on the patent’s scope, potential overlaps, and infringement risks.
- Assess the patent’s novelty against prior art, especially related chemical structures and delivery methods, to gauge strength.
- Monitor jurisdictional patent statuses and expiration dates to identify market entry windows and licensing opportunities.
- Maintain continuous patent landscape surveillance to detect emerging patents that could impact freedom to operate.
- Strategic patent positioning—through filings in key jurisdictions and considering claim narrowing or broadening—can optimize commercial value.
FAQs
1. What is the primary focus of WO2018102145?
It likely pertains to a novel pharmaceutical compound, formulation, or therapeutic method—specific details depend on the claims but generally involve innovative treatment approaches for a defined medical condition.
2. How broad are the patent claims in WO2018102145?
Typically, such patents include a combination of broad independent claims covering core compounds or methods and narrow dependent claims specifying particular structures, formulations, or treatment parameters.
3. How does WO2018102145 fit into the current patent landscape?
It exists within a competitive field with prior patents on similar chemical classes or delivery methods. Its novelty and strategic value depend on how it distinguishes itself from prior art.
4. What are the key considerations for freedom-to-operate (FTO) analysis involving this patent?
Review overlapping claims in the patent family across jurisdictions, assess prior art that may invalidate claims, and identify potential licensing or design-around opportunities.
5. When will WO2018102145 expire, and what does that mean for commercialization?
Patent term is generally 20 years from the filing date, subject to maintenance fees. Its expiry opens opportunities for generic competition, but expiration dates vary per jurisdiction.
References
[1] WIPO Patent Application WO2018102145, Title, Filing date, Assignee.
[2] Patent landscape analyses concerning chemical compounds and therapeutic methods in pharmaceuticals.
[3] Relevant prior art and patent family databases—e.g., Espacenet, WIPO PATENTSCOPE.
